RECURRENT OR METASTATIC COLORECTAL CANCER
Clinical trials for RECURRENT OR METASTATIC COLORECTAL CANCER explained in plain language.
Never miss a new study
Get alerted when new RECURRENT OR METASTATIC COLORECTAL CANCER trials appear
Sign up with your email to follow new studies for RECURRENT OR METASTATIC COLORECTAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to boost immune attack on Hard-to-Treat cancers
Disease control OngoingThis study tests two immunotherapy drugs, durvalumab and monalizumab, in about 383 adults with advanced solid tumors, including colorectal cancer. The goal is to see if the combination is safe and can shrink tumors. Some participants also receive standard chemotherapy or other ta…
Matched conditions: RECURRENT OR METASTATIC COLORECTAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: MedImmune LLC • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for Tough-to-Treat colorectal cancer?
Disease control OngoingThis study tests a new drug called nelmastobart combined with the chemotherapy capecitabine in people with metastatic colorectal cancer that no longer responds to standard treatments. About 59 adults will receive the combination to see if it is safe and can slow cancer growth. Th…
Matched conditions: RECURRENT OR METASTATIC COLORECTAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: Korea University Anam Hospital • Aim: Disease control
Last updated Jun 26, 2026 14:25 UTC